Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Sorcs1 ELISA Kit (AC2638)
Cat.#: ASET-1227
Specifications
Description Mouse Sorcs1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Sorcs1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.62 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1522 Human P Cadherin ELISA Kit (AC2933) Quantitative inquiry ASET-2063 Mouse ABCG1 ELISA Kit (AC3474) Quantitative inquiry ASET-2057 Monkey Adiponectin ELISA Kit (AC3468) Quantitative inquiry ASET-2504 Rat 160 kD Neurofilament Medium ELISA Kit (AC3915) Quantitative inquiry ASET-1639 Human Ataxin 1 ELISA Kit (AC3050) Quantitative inquiry ASET-2178 Mouse Aldh1a7 ELISA Kit (AC3589) Quantitative inquiry ASET-1066 Human UNC5B ELISA Kit (AC2477) Quantitative inquiry ASET-1786 Human NK-1R ELISA Kit (AC3197) Quantitative inquiry ASET-2324 Mouse SEMA3D ELISA Kit (AC3735) Quantitative inquiry ASET-2137 Human Nicastrin ELISA Kit (AC3548) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket